U.S. Leisure Stock News

NYSE:CPRI
NYSE:CPRILuxury

Assessing Capri Holdings (CPRI) Valuation After Recent Mixed Share Price Performance

Capri Holdings stock snapshot after recent moves Capri Holdings (CPRI) has been trading in a mixed pattern recently, with a small 1 day pullback, a modest gain over the past week, and weaker performance over the past month and past 3 months. See our latest analysis for Capri Holdings. At a share price of US$17.96, Capri Holdings has seen short term share price momentum weaken, with a 30 day share price return of 5.32% and a 90 day share price return of 26.36%. The 1 year total shareholder...
NasdaqGM:RAPP
NasdaqGM:RAPPPharmaceuticals

Is Rapport Therapeutics (RAPP) Turning Its TARPγ8 Precision Seizure Program Into a Scalable Platform?

Rapport Therapeutics, Inc. announced it will present Phase 2a trial results for RAP-219 in focal onset seizures, including 8-week follow-up data, at the American Academy of Neurology Annual Meeting in Chicago on April 18–22, 2026. The focus on TARPγ8, a protein expressed in specific brain regions linked to seizure origins but with minimal hindbrain presence, highlights a precision approach that may differentiate RAP-219 from broader-acting neuroscience therapies. We’ll examine how the...
NYSE:AESI
NYSE:AESIEnergy Services

A Look At Atlas Energy Solutions (AESI) Valuation After Recent Share Price Swings

Atlas Energy Solutions (AESI) has been drawing attention after recent share price swings, with a gain over the past month contrasting with weaker returns across the past year and the past 3 months. See our latest analysis for Atlas Energy Solutions. The recent 7 day share price return of a 13.21% decline comes after a 30 day share price return of 22.60% and a 90 day share price return of 25.00%. However, the 1 year total shareholder return of a 20.01% decline shows that momentum has picked up...
NYSE:DD
NYSE:DDChemicals

A Look At DuPont De Nemours (DD) Valuation After Recent Share Price Volatility

Why DuPont de Nemours (DD) is on investors’ radar today Recent share performance has put DuPont de Nemours (DD) back in focus. The stock has shown a 5.8% decline over the past month and an 11.3% gain in the past 3 months. See our latest analysis for DuPont de Nemours. At a share price of US$45.48, DuPont de Nemours has seen short term share price pressure with a 30 day share price return of a 5.8% decline, while longer term momentum is reflected in an 11.3% year to date share price return and...
NasdaqGS:CIFR
NasdaqGS:CIFRSoftware

Cipher Digital (CIFR) Valuation Check After New Hyperscaler Lease And US$200 Million Credit Facility

Cipher Digital (CIFR) has been drawing attention after securing a 15 year data center campus lease with an investment grade hyperscaler and closing a new revolving credit facility. This facility could support further high performance computing growth. See our latest analysis for Cipher Digital. The share price has eased in recent weeks, with a 7 day share price return of 6.73% and a 30 day return of 20.07%, even though the 1 year total shareholder return is very large. Overall, short term...
NYSE:VSH
NYSE:VSHElectronic

Vishay (VSH) Is Up 6.4% After Mixed Quarter And New Auto-Focused Chip Launches - What's Changed

In late March and early April 2026, Vishay Intertechnology reported quarterly results with revenue rising 12.1% year on year but adjusted operating income coming in below expectations, while also launching an Automotive Grade photovoltaic MOSFET driver and a compact high-accuracy linear position sensor for demanding industrial and mobility applications. The new VODA1275 MOSFET driver and 40 LHE position sensor highlight Vishay’s push into higher-value automotive electrification and precision...
NYSE:SMG
NYSE:SMGChemicals

Should JPMorgan’s Downgrade and Hawthorne Exit Plans Require Action From Scotts Miracle-Gro (SMG) Investors?

In late March 2026, JPMorgan downgraded Scotts Miracle-Gro to Neutral, citing rising input costs tied to geopolitical conflict, even as the company reaffirmed its fiscal 2026 guidance and highlighted that most key commodities were already locked in and largely sourced domestically. At the same time, Scotts Miracle-Gro is pushing ahead with a planned Hawthorne divestiture, expanded marketing and an approved share repurchase program, underscoring management’s confidence in its longer-term...
NYSE:TRGP
NYSE:TRGPOil and Gas

Does Record 2025 EBITDA and 2026 Guidance Shift the Bull Case For Targa Resources (TRGP)?

Targa Resources recently reported past fourth-quarter 2025 earnings of US$2.51 per share, beating analyst expectations and helping deliver a record full-year adjusted EBITDA of US$4.96 billion, supported by higher Permian Basin volumes and effective marketing. The company also outlined 2026 adjusted EBITDA guidance of US$5.4 billion to US$5.6 billion and US$2.5 billion in expansion capital spending, underscoring its commitment to growth-oriented infrastructure investment. We’ll now examine...
NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Assessing Newmark Group (NMRK) Valuation After The Artise Refinancing Highlights Market Confidence

Newmark Group (NMRK) has been in focus after its capital markets team arranged a US$525 million refinancing for The Artise, a 25 story, 99% leased office tower in downtown Bellevue, Washington. See our latest analysis for Newmark Group. Newmark’s recent refinancing of The Artise comes after a tough stretch for the share price, with a 90 day share price return of negative 13.79%, even as the 1 year total shareholder return sits at 30.89% and the 3 year total shareholder return at 112.48%. This...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Viatris (VTRS) Valuation In Focus After MR-139 Phase III Failure And Pipeline Setback

Viatris (VTRS) came under pressure after its experimental eye treatment MR-139 failed to meet primary endpoints in two consecutive Phase III trials for blepharitis, a setback that weighed on sentiment. See our latest analysis for Viatris. The share price reaction to the MR-139 trial failure comes after a mixed stretch, with a 30 day share price return of 9.74% offset by a 90 day share price return of 7.87%, while the 1 year total shareholder return of 72.38% and 3 year total shareholder...
NYSE:ACA
NYSE:ACAConstruction

Arcosa (ACA) Valuation Check After Strong Multi Year Shareholder Returns

Why Arcosa Stock Is Drawing Investor Attention Now Arcosa (ACA) has come onto investor radars after its recent share performance, with a small daily decline, modest gains over the past week, and mixed moves over the past month and past 3 months. For anyone tracking industrial and infrastructure related names, this kind of short term volatility can be a prompt to look more closely at what you are actually getting in terms of business mix, recent financial results, and valuation signals. See...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

How Tokenized Deposits And Preferred Payouts At Huntington (HBAN) Reframe Its Digital-Efficiency Story

In late March 2026, Huntington Bancshares’ board declared quarterly cash dividends on its 5.70% Series I and 5.50% Series L Non-Cumulative Perpetual Preferred Stock, with payments scheduled for May 20 and June 1, 2026, to shareholders of record as of April 30 and May 15, respectively. Together with Huntington’s move into a tokenized deposit network and a new SEI wealth platform, these preferred dividends highlight the bank’s focus on modernizing its infrastructure while continuing consistent...
NasdaqGS:POWI
NasdaqGS:POWISemiconductor

How Investors Are Reacting To Power Integrations (POWI) Expanding High-Efficiency Flyback Power Capability With GaN ICs

In March 2026, Power Integrations launched its TOPSwitchGaN flyback IC family, using PowiGaN technology to push flyback converter power capability up to 440 W while improving efficiency, cutting thermal requirements, and lowering system complexity and cost for applications like high-end appliances, e-bike chargers, and industrial power supplies. This innovation expands the practical range of a widely used power-supply architecture, potentially making it easier for equipment makers to meet...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Assessing Vericel (VCEL) Valuation After Winning A US$196.87 Million Government Contract

Contract win reframes Vericel’s setup for investors Vericel (VCEL) recently secured a US$196.87 million contract with the Health and Human Services department, covering procurement of its FDA approved enzymatic debridement product and development of a next generation version. See our latest analysis for Vericel. The contract news has arrived at a time when Vericel’s short term share price return has picked up, with a 1 day move of 4.85% and a 7 day gain of 10.77%. This is the case even though...
NYSE:BLK
NYSE:BLKCapital Markets

A Look At BlackRock’s (BLK) Valuation As Private Credit Scrutiny And Liquidity Concerns Intensify

Heightened scrutiny on BlackRock’s private credit funds BlackRock (BLK) is in the spotlight after US lawmakers and lawyers intensified scrutiny of its private credit vehicles, fund liquidity practices, and governance, following redemption limits in the HPS Corporate Lending Fund and a securities fraud investigation. This scrutiny has sharpened attention on how BlackRock structures, values, and risks its alternative assets. These activities sit alongside its traditional asset management and...
NasdaqGS:MQ
NasdaqGS:MQDiversified Financial

AI Fraud Scoring Upgrade Could Be A Game Changer For Marqeta (MQ)

In late March 2026, Marqeta enhanced its Real-Time Decisioning platform with an AI-powered risk score that assesses transaction risk in real time using over 300 attributes and proprietary card program data to help customers curb payment fraud and reduce false declines. This upgrade stands out because the risk engine continuously adapts to individual cardholder behavior and shifting market patterns, delivering millisecond-level decisions that can refine fraud controls without sacrificing...
NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

The Bull Case For Intuitive Surgical (ISRG) Could Change Following Cyberattack Containment And Da Vinci 5 Approvals

In recent months, Intuitive Surgical reported a phishing attack that accessed certain internal IT business applications but left its da Vinci and Ion robotic systems unaffected, while also delivering a strong quarter with its da Vinci 5 system gaining regulatory approvals in Europe and Japan for a phased rollout and issuing 2026 growth and margin guidance. An interesting angle is how Intuitive’s swift containment of the cyber incident, combined with momentum behind da Vinci 5’s global...
NYSE:NI
NYSE:NIIntegrated Utilities

Should New Data Center Optimism and Analyst Upgrades Require Action From NiSource (NI) Investors?

In March 2026, KeyBanc initiated coverage on NiSource Inc. with an Overweight rating, joining several firms that recently reiterated positive views on the regulated utility. Analysts are emphasizing NiSource’s exposure to growing data center power needs and supportive regulation, while still flagging its elevated debt burden and modest interest coverage. Next, we’ll examine how this fresh analyst optimism around data center-driven demand and regulation could reshape NiSource’s existing...
NYSE:PFS
NYSE:PFSBanks

A Look At Provident Financial Services (PFS) Valuation After Solid Results And New Growth-Focused Hires

Provident Financial Services (PFS) is back on investors' radar after solid quarterly results, a 7.9% stock move in recent months, and fresh hires in wealth management, along with a new Head of Investor Relations. See our latest analysis for Provident Financial Services. The 7.9% share price move in recent months sits within a steadier pattern, with a 90 day share price return of 7.85% and a 1 year total shareholder return of 39.79%. This hints that momentum has been building as quarterly...
NYSE:CSR
NYSE:CSRResidential REITs

Assessing Centerspace (CSR) Valuation As Land & Buildings Lifts Stake And Board Changes Unfold

Event driven moves at Centerspace Land & Buildings recently lifted its stake in Centerspace (CSR) to 9.19%, as the REIT also announced the retirement of board member Emily Nagle Green and declared its latest quarterly dividend. See our latest analysis for Centerspace. Despite the latest $59.90 share price seeing a 3.67% 1 day share price return, Centerspace’s 30 day share price return of 3.94% and year to date share price return of 10.56% suggest momentum has been fading, even as the 3 year...
NasdaqGS:PAGP
NasdaqGS:PAGPOil and Gas

A Look At Plains GP Holdings (PAGP) Valuation As New Shelf Registration Raises Dilution Questions

Plains GP Holdings (PAGP) recently filed a shelf registration for up to US$938.9 million of Class A shares, giving the company flexibility to raise equity capital that could affect future dilution and investor sentiment. See our latest analysis for Plains GP Holdings. At a share price of US$24.06, Plains GP Holdings has logged a 90 day share price return of 23.96% and a 1 year total shareholder return of 26.46%. The new US$938.9 million shelf registration gives context to this recent momentum...
NYSE:KO
NYSE:KOBeverage

Coca-Cola (KO) Valuation Check As New South Africa And Fairlife Investments Target Future Growth

Why Coca-Cola’s latest investments matter for KO shareholders Coca-Cola (KO) is back in the spotlight after outlining two large capital projects: a US$1b plan in South Africa and a US$650 million Fairlife expansion in Michigan, both aimed at supporting future product demand. See our latest analysis for Coca-Cola. Those new projects come as Coca-Cola’s share price has gained 11.0% year to date and 11.0% over 90 days, while its 1-year total shareholder return of 7.88% and 5-year total...
NYSE:EHC
NYSE:EHCHealthcare

Legal Probe Into Care Quality Could Be A Game Changer For Encompass Health (EHC)

Pomerantz LLP is investigating Encompass Health Corporation after a July 15, 2025 New York Times report alleged below-average safety outcomes and serious patient care errors at some of its for-profit hospitals, raising questions about potential securities law violations and business practices. This clash between heightened legal and reputational scrutiny and ongoing confidence from Wall Street analysts creates an unusual tension in how investors may assess Encompass Health’s long-term...
NYSE:LNC
NYSE:LNCInsurance

How Investors Are Reacting To Lincoln National (LNC) Securing a US$2 Billion Unsecured Credit Facility

On March 27, 2026, Lincoln National Corporation entered into an unsecured, third amended and restated credit agreement with a bank syndicate led by Bank of America, providing up to US$2.00 billion in borrowing and letters of credit capacity through March 27, 2031, with fees tied to credit ratings and ongoing financial covenants. This long-dated, covenant-driven facility underscores lenders’ confidence in Lincoln National’s balance sheet discipline and gives the company meaningful financial...